Sierrra Oncology

Sierra Oncology Acquires Gilead’s Stalled Myelofibrosis Drug
Xconomy
Wed, 08/22/18 - 05:47 pm
Gilead Sciences
Sierrra Oncology
myelofibrosis
momelotinib